48,830
edits
Difference between revisions of "Prostate cancer with neuroendocrine differentiation"
Jump to navigation
Jump to search
Prostate cancer with neuroendocrine differentiation (view source)
Revision as of 22:47, 19 March 2018
, 22:47, 19 March 2018→IHC
(→IHC) |
|||
| Line 16: | Line 16: | ||
==IHC== | ==IHC== | ||
*[[PSA]] typically negative in | *[[PSA]] typically negative in neuroendocrine carcinomas. | ||
==See also== | ==See also== | ||